Cite
MLA Citation
Anna Halpern et al.. “Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms.” Leukemia, vol. 32, no. 11, 2018, pp. 2352–2362. http://access.bl.uk/ark:/81055/vdc_100086834412.0x0001aa